framycetin has been researched along with Hyperlipoproteinemia Type II in 20 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 18 (90.00) | 18.7374 |
1990's | 2 (10.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bailey, KR; Bou, E; Gregg, RE; Hoeg, JM; Pikus, AM; Romano, CA; Schaefer, EJ; Sprecher, DL; Wilson, PW; Zech, LA | 1 |
Bailey, KR; Bou, E; Brewer, HB; Gregg, RE; Hoeg, JM; Maher, MB; Pikus, AM; Sprecher, DL; Susser, JK; Zech, LA | 1 |
Schade, RW | 1 |
Kane, JP; Malloy, MJ | 1 |
Miettinen, TA | 2 |
Vanhanen, H | 1 |
Kesäniemi, YA; Miettinen, TA | 1 |
Brewer, HB; Gurakar, A; Hoeg, JM; Kostner, G; Papadopoulos, NM | 1 |
Brewer, HB; Brittain, EH; Farnsworth, WH; Hoeg, JM; Maher, M; Sherins, RJ | 1 |
Nikkilä, EA; Tikkanen, MJ | 1 |
Havel, RJ; Kane, JP | 1 |
Gotto, AM; Jones, PH; Scott, LW | 1 |
Bailey, KR; Brewer, HB; Hoeg, JM; Maher, MB | 2 |
Hoeg, JM; Witebsky, FG; Wu, TC | 1 |
Ayres, EJ; Bailey, KR; Bieri, JG; Hoeg, JM | 1 |
Färkkilä, M; Kesäniemi, YA; Koivisto, P; Miettinen, TA; Vuoristo, M | 1 |
Bailey, KR; Brewer, HB; Gregg, RE; Hoeg, JM; Maher, MB; Sprecher, DL; Zech, LA | 1 |
Lipovetskiĭ, BM; Teriukova, NP; Triufanov, VF | 1 |
4 review(s) available for framycetin and Hyperlipoproteinemia Type II
Article | Year |
---|---|
[Hyperlipoproteinemia type II].
Topics: Adolescent; Adult; Cecum; Child; Cholesterol, Dietary; Cholestyramine Resin; Clofibrate; Coronary Disease; Dextrothyroxine; Diet; Drug Therapy, Combination; Humans; Hyperlipoproteinemia Type II; Ileum; Lipoproteins, LDL; Neomycin; Nicotinic Acids; Plasmapheresis; Portacaval Shunt, Surgical; Xanthogranuloma, Juvenile | 1980 |
Treatment of hypercholesterolemia.
Topics: Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Heterozygote; Homozygote; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols; Thyroxine | 1982 |
Treatment of hypercholesterolemia.
Topics: Animals; Cholestyramine Resin; Clofibrate; Colestipol; Cricetinae; Dogs; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Mice; Middle Aged; Neomycin; Niacin; Pentanoic Acids; Pregnancy; Probucol; Rats | 1986 |
The diagnosis and management of hyperlipidemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dietary Fats; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipoproteins; Lipoproteins, LDL; Neomycin; Niacin; Pentanoic Acids; Probucol; Receptors, LDL; Triglycerides | 1986 |
7 trial(s) available for framycetin and Hyperlipoproteinemia Type II
Article | Year |
---|---|
Neomycin and plasma lipoproteins in type II hyperlipoproteinemia.
Topics: Adult; Analysis of Variance; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hyperlipoproteinemia Type II; Lipoproteins, VLDL; Male; Middle Aged; Neomycin; Prospective Studies; Random Allocation; Triglycerides | 1984 |
Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacin.
Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Lipoproteins; Male; Middle Aged; Neomycin; Niacin; Patient Compliance | 1984 |
Effects of neomycin alone and in combination with cholestyramine on serum cholesterol and fecal steroids in hypercholesterolemic subjects.
Topics: Adult; Bile Acids and Salts; Cholesterol; Cholestyramine Resin; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Therapy, Combination; Feces; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Male; Middle Aged; Neomycin; Sitosterols | 1979 |
Testicular function in type II hyperlipoproteinemic patients treated with lovastatin (mevinolin) or neomycin.
Topics: Adult; Cholesterol; Cholesterol, HDL; Follicle Stimulating Hormone; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Lovastatin; Luteinizing Hormone; Male; Middle Aged; Naphthalenes; Neomycin; Pituitary Function Tests; Prolactin; Testis | 1987 |
The effects of mevinolin and neomycin alone and in combination on plasma lipid and lipoprotein concentrations in type II hyperlipoproteinemia.
Topics: Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Drug Interactions; Drug Therapy, Combination; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoproteins; Lovastatin; Naphthalenes; Neomycin | 1986 |
The effect of neomycin on plasma alpha tocopherol levels in type II hyperlipoproteinemia.
Topics: Cholesterol, LDL; Diet; Female; Humans; Hyperlipoproteinemia Type II; Lipids; Male; Neomycin; Vitamin E | 1986 |
Effects of combination cholestyramine-neomycin treatment on plasma lipoprotein concentrations in type II hyperlipoproteinemia.
Topics: Cholesterol, HDL; Cholesterol, LDL; Cholestyramine Resin; Clinical Trials as Topic; Constipation; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Lipoproteins; Male; Neomycin; Time Factors | 1985 |
9 other study(ies) available for framycetin and Hyperlipoproteinemia Type II
Article | Year |
---|---|
Effects of neomycin alone and in combination with cholestyramine on serum methyl sterols and conversion of acetate and mevalonate to cholesterol.
Topics: Acetates; Cholesterol; Cholestyramine Resin; Feces; Humans; Hyperlipoproteinemia Type II; Mevalonic Acid; Neomycin; Steroids; Sterols | 1982 |
Cholesterol malabsorption caused by sitostanol ester feeding and neomycin in pravastatin-treated hypercholesterolaemic patients.
Topics: Anticholesteremic Agents; Cholesterol; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Intestinal Absorption; Male; Middle Aged; Neomycin; Pravastatin; Sitosterols | 1994 |
Inhibition of cholesterol absorption by neomycin, benzodiazepine derivatives and ketoconazole.
Topics: Anticholesteremic Agents; Benzodiazepines; Cholesterol; Humans; Hyperlipoproteinemia Type II; Intestinal Absorption; Ketoconazole; Neomycin | 1991 |
Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment.
Topics: Adult; Aged; Cardiovascular Diseases; Cholesterol, LDL; Female; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoprotein(a); Lipoproteins; Lipoproteins, VLDL; Male; Middle Aged; Neomycin; Niacin | 1985 |
Current pharmacologic treatment of elevated serum cholesterol.
Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Drug Tolerance; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Probucol; Simvastatin; Triglycerides | 1987 |
Effect of oral neomycin treatment of hyperlipoproteinemia on antibiotic susceptibilities of stool enteric flora.
Topics: Adult; Drug Resistance, Microbial; Enterobacteriaceae; Escherichia coli; Feces; Humans; Hyperlipoproteinemia Type II; Middle Aged; Neomycin | 1986 |
Comparison of six pharmacologic regimens for hypercholesterolemia.
Topics: Adult; Aged; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Neomycin; Niacin; Retrospective Studies | 1987 |
Enhanced cholesterol elimination and synthesis related to low-density lipoprotein metabolism.
Topics: Apolipoproteins B; Benzodiazepines; Bile Acids and Salts; Celiac Disease; Cholesterol; Diet; Feces; Humans; Hyperlipoproteinemia Type II; Ileum; Ketoconazole; Lipoproteins, LDL; Neomycin; Squalene | 1987 |
[Differential use of diet and drugs in dyslipoproteinemias].
Topics: Adult; Clofibrate; Dietary Carbohydrates; Dietary Fats; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type IV; Lipids; Male; Middle Aged; Neomycin | 1985 |